March wasn’t easy on markets. So let’s assess the damage and make a plan.

In this episode, our analysts' cover how their investment ideas are holding up in the real world.

Since their launch in October 2024, the Finimize portfolio has delivered an average absolute annualized return of 25%, beating benchmarks by an annualized 10%, and sits at a 70% “hit rate” – meaning most of the calls made money.

So we're breaking down what worked, what didn’t, and what direction the portfolio takes from here.

Try Finimize Pro

Theon International doesn't make a lot of noise – but maybe it should.

It's a small company, worth under $3 billion, but already showing the kind of traits that rarely turn up together: strong growth, solid margins, and good visibility on future earnings.

Add in a tailwind from rising defense budgets and some smart expansion into new product lines, and Finimize analyst Theodora Lee Joseph thinks you've got a compelling stock for patient investors.

Try Finimize Pro

Healthcare investing isn't always about blockbuster drugs – sometimes the best opportunities hide in profitable niches.

In this episode, we sit down with Finimize analyst Russell Burns to dig into Harrow, an ophthalmology pharma company whose stock has dropped 30% in recent weeks despite a still-strong growth outlook.

With shares up 400% over five years – dwarfing the S&P 500 – Russell explains why this pullback might be the entry point investors have been waiting for.

Try Finimize Pro

The AI boom has a growing problem: it needs an enormous amount of power. Data centers are already pushing electricity grids to their limits, and building new ones on Earth is getting harder, slower, and more expensive.

So some of tech’s biggest names are thinking bigger - and higher. In this episode, Finimize analyst Reda Farran joins the pod to explore the idea of putting data centers in low Earth orbit. It sounds like science fiction, but the logic is gaining attention: near-limitless solar power, fewer land constraints, and a new frontier for AI infrastructure.

Try Finimize Pro

Every month, we open the books.

In this episode, the Finimize team join the pod to review how our investing ideas have actually performed. We go through the winners, the laggards, and the positions that tested our conviction - all tracked publicly, with live numbers.

Since launch in October 2024, the portfolio has delivered a 42% average absolute annualized return, beaten its benchmarks by 19% annualized, and achieved a 76% hit rate.

But performance stats only matter if you understand what’s driving them.

So we break down what worked, what didn’t, and where we see the most compelling opportunities from here.

Try Finimize Pro

Rolls-Royce is one of those stocks that sounds like it should be tapped out by now. The shares are up more than tenfold, the turnaround story is well known - and yet, the valuation debate is only getting louder.

In this episode, Finimize Analyst Theodora Lee Joseph joins the pod. She's been rethinking her long-standing US-centric investing approach and landed on an unexpected name: Rolls-Royce Holdings.

Not the cars - the industrial engine-maker powering aircraft, defense systems, data centers, and potentially nuclear reactors in the years ahead.

Try Finimize Pro

London Stock Exchange Group isn’t a flashy name in the AI boom. It doesn’t build chips or train models. But for years, it’s quietly made money doing something far less glamorous - selling the infrastructure, data, and plumbing that global markets rely on every day.

In this episode, Finimize Analyst Russell Burns joins the pod to talk about why recent fears around AI disrupting financial data have hit London Stock Exchange Group so hard, why the selloff may have gone too far - and ultimately, why it makes the firm a scintillating opportunity.

Try Finimize Pro

Making food from air sounds futuristic, but the investment opportunity is actually...quite down to earth.

In today's episode, Finimize Analyst Reda Farran rejoins the pod to break down his updated outlook of Solar Foods, from product launches to production plans and a key financing step forward.

Some of the story is still about big vision and breakthrough tech. But a growing part of it is about execution, scale, and what the updated valuation says about the potential upside - and the risks - from here.

Try Finimize Pro